Asthma Epidemiology Forecast 2026-2035

Asthma remains a significant public health concern worldwide. In 2022, asthma affected approximately 8.2% of the United States population, representing nearly 26.8 million individuals, reflecting a high asthma prevalence. Prevalence was higher among females (9.7%) compared with males (6.6%), underscoring notable gender-based asthma incidence trends and the continued national burden. These figures highlight the importance of sustained surveillance, prevention, and disease management strategies. According to the asthma epidemiology forecast, the disease burden is expected to remain substantial in the coming years, emphasizing the need for improved treatment approaches and healthcare planning.

Asthma Epidemiology Forecast Report Coverage

The analyst's “Asthma Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of asthma. It projects the future incidence and prevalence rates of asthma cases across various populations. The study covers age, gender, and type as major determinants of the asthma population. The report highlights patterns in the prevalence of asthma over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of asthma in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Asthma Understanding: Disease Overview

Asthma is a chronic respiratory condition characterized by airway narrowing and lung inflammation, leading to breathing difficulty. It develops due to genetic and environmental asthma causes, often activated by asthma triggers such as allergens or pollutants. Common asthma symptoms include wheezing, coughing, and shortness of breath. types include mild asthma, severe asthma, allergic asthma, eosinophilic asthma, occupational asthma, pediatric asthma, and adult asthma. Early asthma diagnosis is essential for effective management and prevention of complications, ensuring timely identification of disease severity and subtype.

Asthma Epidemiology Perspective

The asthma epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the asthma epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for asthma and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Asthma affects over 260.5 million people worldwide, making it one of the most common chronic respiratory diseases globally and a major contributor to long-term morbidity, healthcare utilization, and preventable mortality, reflecting a rising asthma prevalence across diverse populations.
• Asthma prevalence demonstrates a clear sex-based pattern in younger populations, with higher cases observed in males compared with females among individuals aged < 20 years globally, indicating distinct asthma incidence rate variations by demographic group.
• In contrast, epidemiological data indicate a shift in sex distribution after age 20, where females exhibit higher overall asthma prevalence and disease burden compared with males worldwide, highlighting adult asthma prevalence trends across global populations.
• Regional disparities highlight that the highest asthma prevalence is observed in South Asia, East Asia, and high-income North America, whereas low-SDI regions experience disproportionately higher mortality and DALYs, reflecting evolving asthma burden linked to healthcare access gaps.
• Asthma-related mortality and disability-adjusted life years (DALYs) show increased burden in older adult populations, particularly among females in advanced age groups, emphasizing severe asthma epidemiology and its impact on long-term outcomes.

Country-wise Asthma Epidemiology

The asthma epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Asthma continues to represent a substantial public health burden in the United States. In 2022, approximately 8.2% of the total United States population, equivalent to nearly 26.8 million individuals, were reported to have current asthma, reflecting a significant asthma prevalence. The condition affects both pediatric and adult populations and demonstrates measurable differences across demographic groups, highlighting evolving asthma incidence rate patterns in epidemiological assessments. These figures underscore the ongoing clinical and economic impact of asthma nationwide. Sustained public health surveillance and evidence-based management strategies remain critical to reducing disease burden and improving long-term respiratory outcomes.

Asthma: Treatment Overview

Effective management focuses on achieving long-term asthma control through personalized care plans. Standard asthma therapy includes the use of asthma inhalers, such as a rescue inhaler for immediate relief and a preventive inhaler for daily maintenance. Physicians may also prescribe asthma drugs like corticosteroids and bronchodilators to reduce airway inflammation and improve airflow. Treatment strategies vary depending on disease severity and patient profile, with regular monitoring and lifestyle adjustments playing a crucial role in minimizing exacerbations and enhancing overall respiratory function.

Key Questions Answered

• What are the key findings of asthma epidemiology in the 8 major markets?
• What will be the total number of patients with asthma across the 8 major markets during the forecast period?
• What was the country-wise asthma epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of asthma patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of asthma during the forecast period of 2026-2035?
• What are the currently available treatments for asthma?
• What are the disease risks, signs, symptoms, and unmet needs of asthma?

Scope of the Asthma Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of asthma based on several factors.
• Asthma Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The asthma report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.